Quoin Pharmaceuticals (STU:2EB0) Institutional Ownership: 2.28% (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2EB0 Quoin Pharmaceuticals Ltd STU:2EB0
19 GF Score
Price €215.04
! 1 Warning Sign
View Full Analysis

What is Quoin Pharmaceuticals Institutional Ownership?

Quoin Pharmaceuticals STU:2EB0 19 Institutional Ownership is 2.28% as of Jul. 16, 2026. GuruFocus rates STU:2EB0 with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Quoin Pharmaceuticals's institutional ownership is 2.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Quoin Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Quoin Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

Quoin Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Quoin Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quoin Pharmaceuticals Institutional Ownership Chart

Quoin Pharmaceuticals Historical Data

The historical data trend for Quoin Pharmaceuticals can be seen below:

2024-01-31 2024-02-29 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.01 0.01 2.83 3.86 3.53 2.68 2.24 2.24 2.28 2.28
STU:2EB0
19GF Score
Quoin Pharmaceuticals Ltd STU:2EB0
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quoin Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 2.28% mean?
Quoin Pharmaceuticals (STU:2EB0) has a Institutional Ownership of 2.28% as of Jul. 16, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Quoin Pharmaceuticals and its competitors.
Is Quoin Pharmaceuticals' Institutional Ownership too high?
Quoin Pharmaceuticals' current Institutional Ownership is 2.28%. Overall, Quoin Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Quoin Pharmaceuticals' Institutional Ownership compare to RVPH and AIM?
Quoin Pharmaceuticals' Institutional Ownership of 2.28% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Quoin Pharmaceuticals and its competitors. Quoin Pharmaceuticals's current Institutional Ownership is 2.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quoin Pharmaceuticals stock overvalued right now?
Quoin Pharmaceuticals (STU:2EB0) has a current Institutional Ownership of 2.28%. The current Institutional Ownership is 2.28%. Quoin Pharmaceuticals' overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Quoin Pharmaceuticals (STU:2EB0), the current Institutional Ownership is 2.28% as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quoin Pharmaceuticals Business Description

Other Exchanges QNRX:USA
Address 42127 Pleasant Forest Court, Ashburn, VA, USA, 20148-7349
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
19GF Score

Get the complete analysis for STU:2EB0

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€215.04
Price